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Background: The Bcl-2 protein BAK is a key player in mitochondrial apoptosis and responds to a myriad of different
death signals. Activation of BAK is a multistep process that involves a number of conformational changes mediated
by BH3-only proteins or p53 which leads to BAK multimerization and pore formation in the mitochondrial outer
membrane. We previously reported that BAK activation is dependent upon dephosphorylation of both tyrosine and
serine residues. Further, recent reports demonstrated that PP2A activity is required for BAK multimerization. Since
Chk1, a checkpoint kinase involved in the activation of G2 checkpoint, is regulated by PP2A, we therefore hypothesized
that Chk1 is involved in BAK multimerization during cell cycle arrest upon severe DNA damage.
Findings: We now show that treatment of HCT116-WT BAK cells with a Chk1 inhibitor impaired BAK dimerization and
mutimerization when treated with the DNA damaging agents UV or etoposide. As a result there is a concomitant
decrease of cytochrome c release from isolated mitochondria challenged with tBid protein and failure in the activation
of caspase3. Interestingly, co-immunoprecipitation studies suggest that Chk1 is required for recruitment of BH3- only
protein PUMA to BAK. We also showed that Chk1 is associated with BAK upon DNA damage.
Conclusion: These findings novelly demonstrate the involvement of a checkpoint kinase Chk1 is required for BAK
activation and underscores the importance of involvement of Chk1 in mitochondrial apoptosis upon severe DNA
damage.
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Apoptosis block is a hallmark of cancer and may contrib-
ute to aggressive tumour progression. The Bcl-2 family
proteins regulate the mitochondrial pathway of apoptosis
through interactions between the pro-apoptotic proteins
BAK and BAX, the anti-apoptotic Bcl-xL and MCL1, and
the BH3-only proteins such as Bid, Bim, PUMA which ac-
tivate BAK and BAX and or inhibit antiapoptotic proteins
[1]. BAK activation is a complex multistep process. Upon
apoptotic stimuli BAK undergoes a N-terminal conform-
ational change initiated by a ‘hit and run’ either by BH3-
only proteins or p53. This is followed by transient
exposure of BAK BH3 domain which then binds to the
hydrophobic groove of another BAK molecule leading to* Correspondence: aazad03@gmail.com
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distribution, and reproduction in any mediumdimer formation [2,3]. The resulting symmetric homodi-
mers then multimerize to higher order structures via
α6:α6 helices [4] leading to the permeabilization of the
mitochondrial outer membrane followed by the release
of apoptogenic factors like cytochrome c, that in turn
lead to downstream activation of caspase3. Recently a
unified model has been proposed that suggests different
affinities of BH3 proteins for both pro- and anti-apoptotic
proteins [5].
Together with the well-characterised conformational
changes required for BAK activation we recently re-
ported that specific dephosphorylation events are also
required. Firstly, tyrosine dephosphorylation at 108
(Y108) in BAK is required to convert BAK into an ‘acti-
vation-competent’ form which constitutes an obligatory
first step in BAK activation [6]. Secondly, we found that
dephosphorylation at S117 residue by PP2A was re-
quired both for the BAK BH3 domain to gain access totral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly cited.
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and subsequent multimerization [7]. More recently we
have shown that dephosphorylation at tyrosine 110
(Y110) is required for recruitment of Bid to BAK [8].
In response to DNA damage, normal cells arrest in G1
to allow time for DNA to repair or they proceed to
apoptosis if the DNA damage is too severe. Robust gen-
otoxic insults induce apoptosis rather than the cell cycle
checkpoint. Checkpoint kinase Chk1, a serine/threonine
kinase that was first identified in fission yeast as an es-
sential component of the DNA damage checkpoint
[9,10] and a major effector of G2/M-phase DNA damage
checkpoint and S-phase replication checkpoint [11]. Re-
cently it has been reported that anti-apoptotic BCL-2
family protein MCL-1 regulates Chk1 [12]. However the
role of Chk1 in mitochondrial apoptosis remains to be
elucidated. PP2A is known to maintain a regulatory
circuit with checkpoint kinase Chk1 by continuously de-
phosphorylating Chk1 which is itself continuously phos-
phorylated by ATR (Ataxia-telangiectasia-related) [13].
Since we found that PP2A activity was required for BAK
multimerization, one particular focus was to elucidate
whether Chk1 activity is involved in BAK multimeriza-
tion during mitochondrial apoptosis in response to DNA
damage. In the present study we found that Chk1 played
a role in mitochondrial apoptosis.
Chk1 is involved in BAK multimerization upon UV
irradiation
In our recent reports we showed that PP2A activity was
required for mediating BAK activation [7]. Since PP2A
has a regulatory role on Chk1, we reasoned that Chk1
may be involved in BAK activation during cell cycle ar-
rest upon severe DNA damage. We investigated the role
of Chk1 in BAK activation during mitochondrial apop-
tosis using the selective Chk1 inhibitor SB-218078,
which potently inhibits Chk1 activity [14], in HCT116
cells lacking both BAK and BAX expression and recon-
stituted with WT BAK (HCT116-BAK cells). BAK acti-
vation consists of two major steps: an N-terminal
conformational change followed by dimerization and
subsequent multimerization. We first analysed the N-
terminal conformation change by a FACS-based assay to
determine whether SB-218078 could block BAK N-
terminal conformation change when cells were treated
with the inhibitor followed by UV damage. We found
that the Chk1 inhibitor had no effect on BAK N-
terminal conformational change (Figure 1A). We next
analysed whether the Chk1 inhibitor had any impact on
BAK multimerization. Mitochondria were prepared from
cells treated with inhibitor and subjected to the sulfahy-
dryl cross-linker BMH (1,6-bismaleimidohexane, Pierce).
Following UV damage or etoposide treatment alone
BAK readily multimerizes to higher order structures.Prior treatment with the inhibitor results in a significant
reduction of BAK multimerization (Figure 1B and C). As
we noticed before [7,8] the BMH crosslinker reduced
the amount of monomeric BAK even though the total
input levels are the same. To overcome this problem we
used a second sulfhydryl crosslinker, BMOE (Bismalei-
midoethane) that is known to produce only the dimmer
form of BAK rather than multimers [2,7,8]. Using the
same mitochondrial preparations, SB-218078 was able to
reduce BAK dimerization in response to either UV or
etoposide treatment. Previously, we reported two differ-
ent phosphorylation mutants of BAK Y108A, involved in
the initial step of BAK activation, that is, an N-terminal
conformational change [6], and BAK S117A/S117E,
which was required for BAK multimerization [7]. There-
fore, to further understand the importance of Chk1 ac-
tivity in BAK multimerization, we next investigated the
effect of the Chk1 inhibitor on BAK multimerization
with these two phosphorylation mutants of BAK Y108A
and S117A/S117E. As expected, we found that prior
treatment with the Chk1 inhibitor results in inhibition
of BAK multimerization with the Y108A mutant further
in line with the findings that Chk1 activity is not re-
quired for the initial step of BAK activation. The Chk1
inhibitor has no impact on BAK multimerization of ei-
ther S117A, which is refractory to the Chk1 inhibitor, or
the S117E mutant in which BAK multimerization was
severely impaired. Thus, this finding demonstrates that
Chk1 activity is required for BAK activation at a later
stage.
Chk1 activity is required for cytochrome c release and
caspase3 activation after UV damage
The failure of BAK multimerization in the presence of
the Chk1 inhibitor may be due to the inability of the
binding of BH3 proteins. To test this idea, we next ana-
lysed whether Chk1 activity is required for release of
cytochrome c from isolated mitochondria by a previ-
ously established procedure [7,15]. Using purified re-
combinant BH3-activator protein tBid, we found that
when tBid was incubated with mitochondria isolated
from WT cells, cytochrome c was readily detected in the
supernatant fractions (Figure 2A). Consistent with the
multimerization results, tBid failed to release cyto-
chrome c from mitochondria isolated from cells with
prior treatment with the Chk1 inhibitor SB-218078. We
then carried out caspase3 activation assays to further
confirm the functional significance of cytochrome c
release. Activation of caspase3 was inhibited in cells
treated with the Chk1 inhibitor when compared to WT
cells following UV damage (Figure 2B). In addition to
these inhibitor-based assays, we also used Chk1 D130A,
a kinase-dead mutant [16] in HT1080 cells to analyse
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Figure 1 (See legend on next page.)
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Figure 1 Effect of Chk1 inhibitor on BAK activation following DNA damage. (A) BAK N-terminal conformational change was analysed in
HCT116-WT BAK cells by FACS using AB1 epitope that specifically recognizes the N-terminal open conformation of BAK. BAK underwent N-terminal
conformational change causes increase in BAK AB-1 specific fluorescence after UV damage that was not inhibited by prior treatment with Chk1
inhibitor SB-218078 (Calbiochem, n = 3, ± s.e.m.). (B & C) BAK multimerization assay was analysed in HCT116 DKO cells reconstituted with WT BAK as
described in [6]. Mitochondria were isolated from cells treated with or without Chk1 inhibitor (SB −218078) for 30 min either alone or UV (B) radiation
or etoposide treatment (C) for 8 hrs. 70–100 μg of mitochondria were crosslinked with 10 mM BMH (top panel) or 10 mM BMOE (bottom panel). BAK
was detected by rabbit anti BAK monoclonal ab (abcam Y164). The input was the 5% of mitochondrial extracts used in the crosslinking studies to
ensure equal loading (middle panel). Non cross-linked BAK runs as a monomer (M) and also as an intra-molecularly linked monomer (Mx). BAK dimers
(D), trimers (T) and higher order structures are indicated. Note that BMOE only detects monomer and dimer forms of BAK. This is representative of 3
independent experiments. Similarly, multimerization experimemts were performed with BAK Y108A mutant (D), BAK S117A mutant (E) and BAK S117E
(F) mutant in the presence of the Chk1 inhibitor and ± UV.
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compared to the Chk1 D130A mutant (Figure 2C).
Taken together we conclude that Chk1 activity is re-





















Figure 2 Effect of Chk1 inhibitor on cytochrome c release from
mitochondria and caspase activation. (A) Mitochondria were
isolated from HCT116-WT BAK cells and HCT116-WT BAK cells treated
with Chk1 inhibitor (SB-218078) for 30 min. Mitochondria were then
incubated with increasing concentrations (0.5-1 ng/μl) of recombinant
tBid (R&D) at 37°C for 30 min. Mitochondria were then separated into
pellet and supernantant fractions by centrifugation and western
blotted for Cyt c ab (BD pharmingen). An equal amount of mitochondria
not treated with tBid was used as input. (B) Caspase activation was
monitored by immunoblotting with anti cleaved caspase3 antibody
using total cell extracts from HCT116-WT BAK cells treated with or
without Chk1 inhibitor for 30 min following UV. (C) Similarly caspase3
activation was analysed in HT1080 and HT1080-Chk1D-A (Chk1 D130A
transfected in HT1080 cells) by western blotting with anti cleaved
caspase 3 antibody. Actin represents equal loading.The BH3-only protein PUMA is required for Chk1 mediated
apoptosis
BCL-2 family proteins, both anti- and pro-apoptotic,
bind to BAK with different affinities and play an essen-
tial role in BAK activation under various stress condi-
tions. We therefore next asked whether the Chk1
inhibitor interferes with the association between BAK
and anti apoptotic proteins Bcl-xL and MCL1. Following
UV damage in the presence of the Chk1 inhibitor, we
found that Bcl-xL still interacts with BAK whereas, as
expected, Bcl-xL dissociates from BAK upon UV damage
without inhibitor. Although MCL1 is usually degraded
after UV damage [17], however we were then interested
to examine whether MCL1 was able to Co-IP BAK fol-
lowing UV irradiation in the presence of Chk1 inhibitor.
We found that Mcl1 was able to pull down BAK in un-
damaged cells and in cells pre-treated with the Chk1 in-
hibitor (Figure 3A) albeit to a lesser extent. To explore
further the role of Chk1, we also examined the inter-
action between BAK and pro-apoptotic BH3-only pro-
teins PUMA and BIM. We found that similar levels of
BIM were immunoprecipitated by BAK irrespective of
whether the cells were treated with Chk1 inhibitor
following UV damage. But in contrast, less PUMA was
co-precipitated with BAK in the presence of the Chk1
inhibitor compared to untreated following UV damage
(Figure 3B). Thus this result demonstrated that Chk1
may require PUMA for BAK activation. We next investi-
gated the interaction between BAK and Chk1. We found
that following UV damage there is an increased associ-
ation between BAK and Chk1 suggesting that Chk1 is
recruited to BAK during mitochondrial apoptosis upon
DNA damage (Figure 4A). We also analysed the inter-
action between Chk1 and anti-apopototic Bcl-xL and
pro-apoptotic BH3-only protein PUMA. Following UV
damage there is an association between PUMA and
Chk1 similar to that of BAK (Figure 4B). However, com-
pared to UV damage there is more association of Bcl-xL
with Chk1 in untreated cells (Figure 4C) further ensur-
ing that upon UV damage, Bcl-xL dissociates from Chk1



























Figure 3 The ability of BH3 protein and Bcl-2 family protein
binding to BAK in presence of Chk1 inhibitor. (A) Mitochondria
were isolated from HCT116-WT BAK cells treated with or without
Chk1 inhibitor ± prior UV. Mitochondria were then solubilised in 1%
CHAPS buffer (20 mM Tris–HCl pH7.4, 135 mM NaCl, 1.5 mM MgCl2,
1 M EGTA, 10% glycerol, protease and phosphates inhibitor cocktail).
Immunoprecipitations were performed with anti BAK ab (Y164,
abcam) and immunoblotted for Bcl-xL (cell signalling, top panel).
Similar immunoprecipitations were performed with anti MCL-1 and
BAK and was detected by western blotting with rabbit anti BAK ab
(Y164, abcam, bottom panel). (B) Similarly BAK was immunoprecipitated
as described in (A) and immunoblotted for detection of BH3-only
protein PUMA (cell signalling, top panel), Bim (Sigma, middle panel)
and BAK (bottom panel). A big batch of mitochondria was isolated



























Figure 4 Interaction between Chk1 and pro- and anti-apoptotic
Bcl-2 family proteins. (A) Immunoprecipitation was performed
with anti-Chk1 ab (Santacruz) and immunoblotted for BAK (top
panel) and Chk1 (bottom panel). Similar immunoprecipitations were
performed with anti-Chk1 ab and immunoblotted for PUMA (B) and
Bcl-xL (C). In all immunoprecipitation reactions 5% of mitochondrial
extracts was used as input. The non-UV mitochondrial extract was
used in all IgG control immunoprecipitation reactions. (D) Chk1
levels were assessed in mitochondrial extracts of both HC1116-WT
BAK and HT1080 cells following UV treatment or without UV. CoxIV
represents equal loading.
Azad and Storey Cell Communication and Signaling 2014, 12:42 Page 5 of 6
http://www.biosignaling.com/content/12/1/42leads to BAK activation. We then assessed the presence
of Chk1 in the mitochondrial preparation of both
HCT116 and HT1080 cells. Following UV damage, there
were increased levels of Chk1 in mitochondria from
both the cell lines (Figure 4D). To our knowledge this is
the first demonstration of a direct interaction between
checkpoint kinase Chk1 and pro-apoptotic protein BAK.
Taken together our results now identify a novel role
for Chk1 in BAK activation during mitochondrial apop-
tosis. Using Co-IP studies, we provide a novel direct link
between Chk1 and apoptotic machinery but it remains
to be established whether or not BAK is the substrate of
Chk1. The BH3-only protein PUMA interferes with the
binding to BAK in the presence of the Chk1 inhibitorand therefore suggests that Chk1 is responsible for the
recruitment of PUMA to BAK. It was previously re-
ported that transactivation of PUMA was restored dur-
ing ATR-mediated activation of Chk1 [18]. Chk1 is
regulated by PP2A and evidence for the complex
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ported [13]. PP2A activity influences many aspects of
the DNA damage response. We recently showed that
PP2A activity is required for BAK multimerization [7].
However, the role of Chk1 activity stimulating PP2A ac-
tivity during mitochondrial apoptosis following DNA
damage by UV or etoposide remains to be established.
Thus, a dual role for Chk1 can be suggested. Chk1
maintains the DNA damage checkpoint integrity, how-
ever, if cells have sustained severe DNA damage and are
no longer repairable, Chk1 may then play a role in apop-
tosis by interacting with BAK. Recently it has been re-
ported that Chk1 is activated by caspase-dependent
cleavage during apoptosis [19]. In response to DNA
damage Chk1 becomes phosphorylated on several serine
residues (S280, S296, S317 and S345) and plays import-
ant functions in cellular processes. Thus, it would be im-
portant to investigate the role of this phosphorylation in
BAK activation. Moreover, in this study we used mostly
HCT116 cells which is lacking mismatch repair and
Chk1 is also involved in mismatch repair (mmr). How-
ever our finding is not due to the abnormalities in mmr
rather due to the inhibition of Chk1 activity as we found
that caspase3 activation is also inhibited in HT1080
cells. Finally, Chk1 is may be responsible for a providing
a safe guarding mechanism for the cell, so that it is
poised to undergo apoptosis if DNA damage is detected
and cannot be repaired.
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